Finished at 0.0150 and the company issued the following release today:
Hard to Treat Diseases (HTDS) Obtains GMP Certificate from Russian FDA
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Learn how to make money the MYMAN way and learn how to live the MYMAN lifestyle by following, MYMAN. MYMAN cares about one thing and one thing only: Makin' money and having the ladies, my man. Get Rich or Die Tryin'
What do you use to buy and sell stocks, my man?
Followers
Blog Archive
-
▼
2009
(224)
-
▼
October
(55)
- Happy Halloween, my man
- Might be worth it to load up on Lifeline Biotech (...
- AVAX Currently Pending Clinical Trials News for it...
- Much needed distraction from biotech stocks in the...
- What does Genta offer us now, my man?
- Bad news today from Genta, my man
- Genta conference call Thursday October 29, 2009 at...
- Take a look at Mammoth Energy Group (MMTE), my man
- Why You Can't Get the Swine Flu Vaccine
- Two great buys under one dollar, my man
- HTDS to acquire a stem cell company, my man?
- Keep an eye on BizAuctions (BZCN), my man
- For a brief shinning moment HTDS was at 0.11 cents...
- FDA OKs Use of BioCryst Flu Drug, my man
- Don't forget about ChinaBioToday, my man
- How much longer must we wait for a decision on Amp...
- Lots of talk about Biovest International (BVTI.PK)...
- A little more about Wellstar International (WLSI),...
- Can we have a Friday touchdown, my man?
- NeoPharm, Inc. (OTC: NEOL), my man
- I have loaded up on Wellstar International (WLSI),...
- Hard To Treat Diseases at 0.0100, my man
- You think HEB sucks? I understand, my man
- No big CTIC bump today, my man
- Keep an eye on Cell Therapeutics on Thursday, my man
- Ampligen is still in limbo, my man
- Speculative stock: China SXAN Biotech, Inc. (Pub...
- Keep an eye on AVAX Technologies (AVXT), my man
- Damn!
- Have a nice weekend, my man
- FDA - Federal Delay Agency
- FierceBiotech: On the Radar: Keep an eye on these...
- Hemispherx BioPharma today, my man
- Some of my favorite long-term stocks,my man
- ASFX and IMDS doing well today, my man
- MultiCell Technologies, Inc. is 'One to Watch', my...
- Will this be the week that BioElectronics busts ou...
- Industry leaders express concern as FDA clamps dow...
- ZZZZZZZZ....Hemispherx BioPharma, my man
- What happens on Friday with Hemispherx BioPharma, ...
- Keep an eye on Imaging3, Inc. (IMGG), my man
- Nice day for Hard to Treat Diseases (HTDS), my man
- Update on NeoPharm (NEOL), my man
- Just because I can, my man
- Peregrine Pharmaceuticals, Inc. (PPHM), my man
- Advanced Cell Technology now on the OTCBB, my man
- Transdel Pharmaceuticals announces positive Phase ...
- Cell Therapeutics is a buy under a $1, my man
- Transdel Pharmaceuticals: Phase 3 clinical study r...
- The CEO of Angiotech Pharmaceuticals (ANPI) brough...
- Take a look at AVAX Technologies, (OTC:AVXT), my man
- ScienceDaily: Umbilical Cord Blood As A Readily Av...
- FDA calendar for October, my man
- Take a look at Advaxis, Inc. (OTCBB: ADXS), my man
- Cell Therapeutics poll results, my man
-
▼
October
(55)
No comments:
Post a Comment